Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms

Antitumour activity of docetaxel (Taxotere®) in hormone-dependent (HD) and hormone-independent (HID) prostate cancer PAC120 xenograft model was previously reported, and its level was associated with HER2 protein expression. In the present study, we evaluate the antitumour effects of docetaxel combin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Legrier, M-E, Oudard, S, Judde, J-G, Guyader, C, de Pinieux, G, Boyé, K, de Cremoux, P, Dutrillaux, B, Poupon, M-F
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2007
Soggetti:
Translational Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359985/
https://ncbi.nlm.nih.gov/pubmed/17211467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603553
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi